CONMED Corp
CONMED Corporation (NYSE: CNMD) is a medical technology company that designs, manufactures, and distributes surgical devices and equipment used by healthcare professionals across multiple specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. The company operates from… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What CONMED Corp does
In the company’s own words
CONMED Corporation (NYSE: CNMD) is a medical technology company that designs, manufactures, and distributes surgical devices and equipment used by healthcare professionals across multiple specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. The company operates from its headquarters in Largo, Florida with approximately 3,900 full-time employees and three primary manufacturing locations serving over 100 countries worldwide. The company's website is www.conmed.com.
CONMED's business is organized into two primary segments: orthopedic surgery and general surgery, which generated 42 percent and 58 percent of consolidated net sales respectively in 2025. The orthopedic surgery division offers products for sports medicine injuries including soft tissue fixation systems, powered resection instruments, fluid management systems, and bone power tools marketed under brands such as BioBrace, TruShot, Y-Knot, Hall, and CONMED Linvatec. The general surgery division provides advanced surgical technologies including the AirSeal insufflation system with valveless access ports, smoke evacuation products from the Buffalo Filter acquisition, electrosurgical generators, endomechanical instruments, and endoscopic technologies for gastroenterology and pulmonology procedures.
The company generated consolidated net sales of approximately $1.37 billion in 2025, with approximately 32 percent of revenues derived from international markets. Approximately 78 percent of orthopedic surgery revenue and 92 percent of general surgery revenue came from single-use products expected to be recurring. CONMED distributes its products directly to more than 6,000 hospitals, surgery centers, and healthcare institutions domestically and through medical specialty distributors and independent country dealers internationally.
CONMED has built its business through strategic acquisitions, internal product development, and distribution relationships to diversify its product offerings and increase market share. The company maintains substantial intellectual property including United States patents and foreign equivalents covering products with expiration dates extending to 2043. Substantially all facilities maintain certification under International Organization for Standardization quality standards and other domestic and international quality accreditations, positioning the company to compete effectively against larger manufacturers and specialized competitors in the global surgical device markets.
Company details
- Sector
- Healthcare
- Industry
- Electromedical Apparatus
- Headquarters
- LARGO, FL
- Fiscal year end
- December
- CIK
- 816956
- SIC
- 3845
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns CONMED Corp — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · CONMED Corp’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
CONMED Corp’s bonds, as funds hold them
Funds report holding 1 issues of CONMED Corp’s debt, $56.37M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 2.25%, maturing 2027 to 2027.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do CONMED Corp and its peers compare on margins and cash generation over ten years?”
- “Where did five years of CONMED Corp's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in CONMED Corp's last four quarterly filings that the numbers alone won't show?”